Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,865 | -2,411 | -19,481 | -9,075 | -2,781 |
| Depreciation Amortization | 410 | 69 | 11,942 | 3,217 | 1,361 |
| Income taxes - deferred | N/A | N/A | N/A | -2,392 | -3,489 |
| Accounts receivable | N/A | N/A | 967 | -779 | -3,188 |
| Other Working Capital | -370 | 1,024 | -1,029 | -496 | 344 |
| Other Operating Activity | 2,936 | 670 | 5,035 | 6,783 | 5,049 |
| Operating Cash Flow | $-3,889 | $-648 | $-2,566 | $-2,741 | $-2,704 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 6 | -5 | -29 |
| Net Acquisitions | N/A | N/A | -3,646 | -165 | -6,563 |
| Other Investing Activity | -44 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-44 | $N/A | $-3,639 | $-170 | $-6,592 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,862 | 560 | -1,976 | 2,153 | 3,795 |
| Debt Repayment | -192 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 488 | N/A | 6,328 | 4,899 | 5,000 |
| Other Financing Activity | 3,373 | 0 | -1,658 | -639 | 3 |
| Financing Cash Flow | $5,531 | $560 | $2,694 | $6,413 | $8,798 |
| Exchange Rate Effect | -64 | 18 | N/A | N/A | N/A |
| Beginning Cash Position | 44 | 114 | 4,882 | 1,380 | 1,878 |
| End Cash Position | 1,579 | 44 | 1,371 | 4,882 | 1,380 |
| Net Cash Flow | $1,535 | $-70 | $-3,511 | $3,502 | $-498 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,889 | -648 | -2,566 | -2,741 | -2,704 |
| Capital Expenditure | N/A | N/A | 6 | -5 | -29 |
| Free Cash Flow | -3,889 | -648 | -2,559 | -2,746 | -2,733 |